Newsroom
Sorted by: Latest
-
Die endgültigen Ergebnisse der MINT-Studie untermauern die Erkenntnisse aus der Praxis zu Mogamulizumab (Poteligeo®) bei Patienten mit Mycosis fungoides und Sézary-Syndrom
GALASHIELS, Schottland & MARLOW, England--(BUSINESS WIRE)--Kyowa Kirin International plc, eine hundertprozentige Tochtergesellschaft der Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), gab heute die endgültigen Ergebnisse der deutschen MINT-Studie bekannt, in der Mogamulizumab bei Patienten mit Mycosis fungoides (MF) und dem Sézary-Syndrom (SS) untersucht wurde. Die Ergebnisse, die auf der Jahrestagung 2026 der Cutaneous Lymphoma Tumour Group (EORTC-CLTG) der Europäischen Organisation für Krebsf...
-
I risultati finali dello studio MINT consolidano le evidenze della pratica clinica reale su mogamulizumab (Poteligeo®) nei pazienti affetti da micosi fungoide e da sindrome di Sézary
GALASHIELS, Scozia, e MARLOW, Inghilterra--(BUSINESS WIRE)--Kyowa Kirin International plc, una sussidiaria controllata al 100% da Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), oggi ha annunciato i risultati finali dello studio MINT condotto in Germania per la valutazione di mogamulizumab nei pazienti affetti da micosi fungoide (MF) e dalla sindrome di Sézary (SS). Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono...
-
Samenvatting: Definitieve resultaten van de MINT-studie versterken bewijs uit de praktijk voor mogamulizumab (Poteligeo®) bij patiënten met mycosis fungoides en sézarysyndroom
GALASHIELS, Schotland & MARLOW, Engeland--(BUSINESS WIRE)--Kyowa Kirin International plc, een dochteronderneming volledig in handen van Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), maakte vandaag de definitieve resultaten bekend uit de Duitse MINT-studie ter beoordeling van mogamulizumab bij patiënten met mycosis fungoides (MF) en sézarysyndroom (SS). Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met...
-
DPC Holdings Agrees to Dispose of Ivostud to DUBAG Group
ST HELIER, Jersey--(BUSINESS WIRE)--DPC Holdings (NYSE: DPC) (“Doncasters”) has agreed to dispose of the Ivostud business to Lenbach Equity Opportunities III. GmbH & Co. KG, a private equity fund advised by DUBAG Group, subject to any required approvals and customary closing conditions, with completion expected during Q4 2026. Ivostud is a non-material asset held for sale.Caution Concerning Forward-Looking StatementsThis press release contains forward-looking statements. Statements included...
-
Xtrackers II UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 09 October 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, an...
-
Antonio Banderas to Star as Hernán Cortés in Epic Feature Film ‘Cortés,’ Directed by Paul Mignot
PARIS--(BUSINESS WIRE)--ANTONIO BANDERAS TO STAR AS HERNÁN CORTÉS IN EPIC FEATURE FILM ‘CORTÉS,’ DIRECTED BY PAUL MIGNOT...
-
Corvias Foundation Launches Vocational Scholarship for Military-Connected Students
WARWICK, R.I.--(BUSINESS WIRE)--The nonprofit Corvias Foundation today announced the launch of its Purple Tassel Vocational Achievement Scholarship, creating a new scholarship opportunity for military-connected students pursuing skilled trades, technical training, certifications, apprenticeships, and other vocational careers. The scholarship will award up to $10,000 to eligible high school seniors from active-duty military families stationed at a Corvias-managed installation. "Success after hig...
-
U.S. Employers Integrate Health Benefits Ecosystems
STAMFORD, Conn.--(BUSINESS WIRE)--An ISG Provider Lens® report says organizations in the U.S. are seeking more integrated operating models for health and welfare benefits....
-
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages The Chemours Company (CC) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff motion.IF YOU SUFFERED A LOSS O...
-
Keysight Showcases Link Layer Retry Interoperability with Alibaba Cloud at 2026 OCP Global Summit
SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight will demonstrate multi-vendor interoperability of Link Layer Retry for the first time at the 2026 OCP Global Summit October 12 - 15....